We describe a case of a 2-month-old female displaying clinical phenotype
of HIES related disease with severe eczematous dermatitis recalcitrant
to corticosteroids. Genetic panel showed a variant of unknown
significance in key immune regulator of PGM3. Patient achieved nearly
complete response from off-label use of dupilumab.